Joel Greenblatt - Gotham Asset Management
Holding/activity history for Caris Life Sciences, Inc. (CAI)
← All CAI superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 744,426 | 0.04 | Add 1008.01% | 0.04 | $16.28–29.32 · VW $21.86i | $13,310,337 | SEC |
| 2025 Q4 | 67,186 | <0.01 | Add 102.35% | <0.01 | $22.86–33.65 · VW $27.25i | $1,812,678 | SEC |
| 2025 Q3 | 33,203 | <0.01 | Buy | <0.01 | $25.40–42.50 · VW $32.12i | $1,004,391 | SEC |
Price snapshot:
Current price$17.06
Avg. buy price$18.85
+/- since buy-9.48%
52-week low$14.19
52-week high$42.50